Elena Marangon

839 total citations
31 papers, 632 citations indexed

About

Elena Marangon is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Elena Marangon has authored 31 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Hematology. Recurrent topics in Elena Marangon's work include Cancer therapeutics and mechanisms (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Treatment and Pharmacology (5 papers). Elena Marangon is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Treatment and Pharmacology (5 papers). Elena Marangon collaborates with scholars based in Italy, United States and United Kingdom. Elena Marangon's co-authors include Giuseppe Toffoli, Bianca Posocco, Maurizio D’Incalci, Massimo Zucchetti, Federica Sala, Renzo Bagnati, Eva Dreussi, Marco Agostini, Sara Crotti and Sara Gagno and has published in prestigious journals such as Blood, PLoS ONE and Analytical Chemistry.

In The Last Decade

Elena Marangon

31 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Marangon Italy 16 311 207 92 78 75 31 632
Bianca Posocco Italy 17 243 0.8× 192 0.9× 60 0.7× 121 1.6× 74 1.0× 43 738
Dennis Greenslade United Kingdom 7 143 0.5× 365 1.8× 30 0.3× 81 1.0× 33 0.4× 8 662
Xiaohai Li China 16 329 1.1× 205 1.0× 47 0.5× 79 1.0× 36 0.5× 33 889
Leanne Embree Canada 12 171 0.5× 155 0.7× 61 0.7× 28 0.4× 88 1.2× 15 557
Weibin Chen China 15 665 2.1× 193 0.9× 47 0.5× 44 0.6× 71 0.9× 45 1.1k
Po‐Chang Chiang United States 17 145 0.5× 113 0.5× 15 0.2× 117 1.5× 53 0.7× 57 795
Michèle Masquelier Sweden 17 427 1.4× 218 1.1× 88 1.0× 74 0.9× 65 0.9× 34 962
Nallaperumal Chidambaram India 14 537 1.7× 319 1.5× 104 1.1× 281 3.6× 54 0.7× 25 1.3k
Kumiko Harada Japan 15 384 1.2× 153 0.7× 21 0.2× 47 0.6× 75 1.0× 51 710
Jon S. B. de Vlieger Netherlands 17 246 0.8× 55 0.3× 50 0.5× 15 0.2× 104 1.4× 23 705

Countries citing papers authored by Elena Marangon

Since Specialization
Citations

This map shows the geographic impact of Elena Marangon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Marangon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Marangon more than expected).

Fields of papers citing papers by Elena Marangon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Marangon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Marangon. The network helps show where Elena Marangon may publish in the future.

Co-authorship network of co-authors of Elena Marangon

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Marangon. A scholar is included among the top collaborators of Elena Marangon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Marangon. Elena Marangon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gagno, Sara, Elena Marangon, Michela Guardascione, et al.. (2020). A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma. Journal of Pharmaceutical and Biomedical Analysis. 187. 113358–113358. 15 indexed citations
2.
Posocco, Bianca, Sara Gagno, Michela Guardascione, et al.. (2020). Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application. PLoS ONE. 15(2). e0228822–e0228822. 34 indexed citations
3.
Marangon, Elena, Paola Posocco, Cristina Forzato, et al.. (2020). Fluorescent Imprinted Nanoparticles for the Effective Monitoring of Irinotecan in Human Plasma. Nanomaterials. 10(9). 1707–1707. 4 indexed citations
4.
Posocco, Bianca, Marcella Montico, Elena Marangon, et al.. (2019). Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients. PLoS ONE. 14(11). e0225225–e0225225. 24 indexed citations
5.
Posocco, Bianca, Sara Crotti, S. DaRonco, et al.. (2018). Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine. Journal of Pharmaceutical and Biomedical Analysis. 160. 360–367. 25 indexed citations
6.
DaRonco, S., Sara Crotti, Pietro Traldi, et al.. (2017). Field‐assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma. Journal of Mass Spectrometry. 52(5). 283–289. 3 indexed citations
7.
Guida, Filomena, Ivan Gladich, Elena Marangon, et al.. (2017). Peptide biosensors for anticancer drugs: Design in silico to work in denaturizing environment. Biosensors and Bioelectronics. 100. 298–303. 19 indexed citations
8.
Toffoli, Giuseppe, Manish Sharma, Elena Marangon, et al.. (2016). Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 23(4). 918–924. 31 indexed citations
9.
DaRonco, S., Sara Crotti, Giuseppe Toffoli, et al.. (2016). Field-Assisted Paper Spray Mass Spectrometry for the Quantitative Evaluation of Imatinib Levels in Plasma. European Journal of Mass Spectrometry. 22(5). 217–228. 5 indexed citations
10.
Crotti, Sara, Bianca Posocco, Elena Marangon, et al.. (2015). Mass spectrometry in the pharmacokinetic studies of anticancer natural products. Mass Spectrometry Reviews. 36(2). 213–251. 18 indexed citations
11.
12.
13.
Sala, Federica, Elena Marangon, Renzo Bagnati, et al.. (2014). Quantification of trabectedin in human plasma: Validation of a high-performance liquid chromatography–mass spectrometry method and its application in a clinical pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 95. 107–112. 12 indexed citations
14.
Gallerani, Elisa, Massimo Zucchetti, Elena Marangon, et al.. (2012). A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma. European Journal of Cancer. 49(2). 290–296. 71 indexed citations
15.
Caffo, Orazio, Stefania Fallani, Elena Marangon, et al.. (2010). Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 65(6). 1197–1202. 10 indexed citations
16.
17.
Bagnati, Renzo, Giuseppe Bianchi, Elena Marangon, et al.. (2007). Direct analysis of isopropylthioxanthone (ITX) in milk by high‐performance liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 21(13). 1998–2002. 27 indexed citations
18.
19.
D’Incalci, Maurizio, Elena Marangon, Matteo Simone, et al.. (2007). Modulation of Gene Transcription by Natural Products - A Viable Anticancer Strategy. Current Pharmaceutical Design. 13(27). 2744–2750. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bianca Posocco Breakdown of academic impact, for papers by Dennis Greenslade Breakdown of academic impact, for papers by Xiaohai Li Breakdown of academic impact, for papers by Leanne Embree Breakdown of academic impact, for papers by Weibin Chen Breakdown of academic impact, for papers by Po‐Chang Chiang Breakdown of academic impact, for papers by Michèle Masquelier Breakdown of academic impact, for papers by Nallaperumal Chidambaram Breakdown of academic impact, for papers by Kumiko Harada Breakdown of academic impact, for papers by Jon S. B. de Vlieger
Rankless by CCL
2026